Six states and one U.S. territory selected to assess feasibility of integrating whole genome sequencing into public health newborn screening Boston, MA Investigators leading BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening) today announced two major milestones in an NIH-funded research effort to evaluate genomic newborn screening: the selection of participating state… Continue reading BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study

Ariadne Labs has launched a Rural Home Hospital Accelerator to help hospitals across the U.S. jumpstart efforts to transform rural healthcare. Through the nine-month program, hospitals serving rural populations will gain access to the tools, expertise, and support needed to successfully launch a home hospital program. Access to high-quality, high-value acute care services in rural… Continue reading Announcing the Rural Home Hospital Accelerator and Request for Applications

Dr. Asaf Bitton pens a call to action published by the Millbank Memorial Fund on his vision of a “triple double” for primary care by 2030.

Drs. Asaf Bitton and Bruce Finke join the Healthcare Reformed podcast in a wide-ranging discussion on the strengths and weaknesses of the American primary care system and the importance of the relationship between a patient and their doctor to deliver better care.

Dr. Asaf Bitton speaks with Dr. Lisa Rosenbaum on the New England Journal of Medicine’s Alive and Kicking, Not Otherwise Specified Podcast to discuss the primary health care system in the United States.

Announcing the launch of BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), the nation’s first multi-state genomic newborn screening initiative.

Dr. Robert Green takes the Ted Talks main stage to talk the future of medicine and genetic sequencing.

Ariadne Labs incubates and spins out Unravel Healthcare Inc., a new independent organization advancing our shared mission to improve childbirth care everywhere

MGB coverage on the International Consortium of Newborn Sequencing (ICoNS) publishing of their findings and tool in Genetics in Medicine. They identified key factors influencing gene inclusion in newborn genomic screening programs and the team developed a machine learning model incorporating 13 predictors, achieving high accuracy in predicting gene selection across programs.

The New York Times covers Dr. Rose Molina and her co-authors’ new research published in JAMA Network Open.